Yibo Chen

Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells.

C. Chou, Ruixin Li, Xin Chen, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

MiR-125b-5p modulates the function of regulatory T cells in tumor microenvironment by targeting TNFR2

Ping Li, Hui Li, Huanhuan He, 2022, Journal for immunotherapy of cancer.

TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4^+Foxp3^+ regulatory T cells

Md. Sahidul Islam, C. Chou, D. Faustman, 2022, Cellular Oncology.

TNFR2 antagonsitic antibody induces the death of tumor in�ltrating CD4+Foxp3+ regulatory T cells

Jiarui Liu, Yibo Chen, Tianzhen He, 2022 .

TNFR2-expressing CD4+Foxp3+ regulatory T cells in cancer immunology and immunotherapy.

Rui Li, Yuanjia Hu, Xin Chen, 2019, Progress in molecular biology and translational science.

Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells

Md. Sahidul Islam, C. Chou, Xin Chen, 2020, Science Advances.

Ancient herbal component may be a novel therapeutic for gouty arthritis

Xin Chen, Yibo Chen, 2018, Journal of leukocyte biology.

Therapeutic potential of TNFR2 agonists: a mechanistic perspective

Xin Chen, Yibo Chen, Mengmeng Jiang, 2023, Frontiers in immunology.